PharmaEngine, Inc.

NT$52.90As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4162Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (9.00%)
Div yield 3.78%
ROE 11.26%
Biotechnology
Beta (5Y) 0.08
PE TTM 14.11
TSR TTM (23.12%)
Mkt cap NT$7.601B
ROIC 36.03%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$58
9.84%
(83.75%)
Buy 8|0|6|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.72
0.77
0.83
0.82
10.37%
23.92%
37.83%
23.08%
RevenueNT$M
721.1
721.2
748.3
790.4
8.14%
9.49%
11.96%
14.93%
Peers (US$229.6M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.716
0.171
0.149
EBIT/Intx
0.661
1.311
1.163
Own earn%
(6.62)
(109.91)
(89.08)
Sh yield%
23.09
31.80
33.79
Owners
Insiders/Inst%
7.21
69.23
Short interest%
2.09
SBC / revenue%
5.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
2–6
$1 testx
0.5
Incr. ROIC%
46